Michael Fleischhacker

Ernst Grube Str. 40
Halle, NI 06120, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 14 publications

Cell-Free Methylated PTGER4 and SHOX2 Plasma DNA as a Biomarker for Therapy Monitoring and Prognosis in Advanced Stage NSCLC Patients.

Cell-Free Methylated PTGER4 and SHOX2 Plasma DNA as a Biomarker for Therapy Monitoring and Prognosis in Advanced Stage NSCLC Patients.

Journal: Diagnostics (Basel, Switzerland)

Published: May 03, 2023

Towards systematic nomenclature for cell-free DNA.

Towards systematic nomenclature for cell-free DNA.

Journal: Human genetics

Published: September 01, 2020

Editorial for "Longitudinal cell-free DNA analysis in patients with small cell lung cancer reveals dynamic insights into treatment efficacy and disease relapse".

Editorial for "Longitudinal cell-free DNA analysis in patients with small cell lung cancer reveals dynamic insights into treatment efficacy and disease relapse".

Journal: Translational lung cancer research

Published: February 02, 2019

Preanalytical challenges - time for solutions.

Preanalytical challenges - time for solutions.

Journal: Clinical chemistry and laboratory medicine

Published: December 17, 2018

Plasma mSEPT9: A Novel Circulating Cell-free DNA-Based Epigenetic Biomarker to Diagnose Hepatocellular Carcinoma.

Plasma mSEPT9: A Novel Circulating Cell-free DNA-Based Epigenetic Biomarker to Diagnose Hepatocellular Carcinoma.

Journal: EBioMedicine

Published: March 14, 2018

Corrigendum to "Liquid biopsy - Performance of the PAXgene® Blood ccfDNA Tubes for the isolation and characterization of cell-free plasma DNA from tumor patients" [Clin. Chim. Acta 469 (2017) 94-98].

Corrigendum to "Liquid biopsy - Performance of the PAXgene® Blood ccfDNA Tubes for the isolation and characterization of cell-free plasma DNA from tumor patients" [Clin. Chim. Acta 469 (2017) 94-98].

Journal: Clinica chimica acta; international journal of clinical chemistry

Published: May 08, 2017

Liquid biopsy - Performance of the PAXgene® Blood ccfDNA Tubes for the isolation and characterization of cell-free plasma DNA from tumor patients.

Liquid biopsy - Performance of the PAXgene® Blood ccfDNA Tubes for the isolation and characterization of cell-free plasma DNA from tumor patients.

Journal: Clinica chimica acta; international journal of clinical chemistry

Published: March 07, 2017

Title Not Found

Title Not Found

Journal: Pneumologie (Stuttgart, Germany)

Published: December 09, 2016

Liquid Profiling in Lung Cancer - Quantification of Extracellular miRNAs in Bronchial Lavage.

Liquid Profiling in Lung Cancer - Quantification of Extracellular miRNAs in Bronchial Lavage.

Journal: Advances in experimental medicine and biology

Published: October 19, 2016

Extracellular microRNAs in bronchoalveolar lavage samples from patients with lung diseases as predictors for lung cancer.

Extracellular microRNAs in bronchoalveolar lavage samples from patients with lung diseases as predictors for lung cancer.

Journal: Clinica chimica acta; international journal of clinical chemistry

Published: June 15, 2015

Elevated levels of the complement activation product C4d in bronchial fluids for the diagnosis of lung cancer.

Elevated levels of the complement activation product C4d in bronchial fluids for the diagnosis of lung cancer.

Journal: PloS one

Published: November 20, 2014

Quantification of cell-free mSHOX2 Plasma DNA for therapy monitoring in advanced stage non-small cell (NSCLC) and small-cell lung cancer (SCLC) patients.

Quantification of cell-free mSHOX2 Plasma DNA for therapy monitoring in advanced stage non-small cell (NSCLC) and small-cell lung cancer (SCLC) patients.

Journal: PloS one

Published: September 16, 2014

Showing 1-12 of 14

Last Updated: 09/26/2026